Practical consensus recommendations on ovarian suppression in early breast cancer (adjuvant)

M Singhal, TP Sahoo, S Aggarwal, A Singhvi, V Kaushal, S Rajpurohit, KM Parthasarthi, A Vora, M Ganvir, S Gupta, Purvish M Parikh

South Asian Journal of Cancer 2018 7(2):151-155

Substantial survival benefits exist for patients with early-stage breast cancer who undergo treatment with single-modality ovarian suppression, but its value is uncertain. Expert oncologist discussed to determine whether additional benefits exist with ovarian suppression plus multiple adjuvant therapy which provides a new treatment option that reduces the risk of recurrence in early breast cancer. This expert group used data from published literature, practical experience and opinion of a large group of academic oncologists to arrive at this practical consensus recommendations for the benefit of community oncologists.

https://ift.tt/2H03rFo